T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortinet
FTNT
|
+$2.03B |
| 2 |
Rockwell Automation
ROK
|
+$1.44B |
| 3 |
Autodesk
ADSK
|
+$1.15B |
| 4 |
Citigroup
C
|
+$975M |
| 5 |
ConocoPhillips
COP
|
+$967M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.59B |
| 2 |
GE Aerospace
GE
|
+$1.78B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.38B |
| 4 |
Meta Platforms (Facebook)
META
|
+$1.08B |
| 5 |
Philip Morris
PM
|
+$1.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.21% |
| 2 | Healthcare | 15.42% |
| 3 | Financials | 10.99% |
| 4 | Consumer Discretionary | 10.39% |
| 5 | Communication Services | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2101
Maravai LifeSciences
MRVI
$861M
| $639K | ﹤0.01% |
73,595
+3,575
| +5% | +$24.2K |
|
|
RWT
2102
Redwood Trust
RWT
$599M
| $639K | ﹤0.01% |
100,209
| – | – |
|
2103
TriMas Corp
TRS
$1.39B
| $639K | ﹤0.01% |
23,870
+1,478
| +7% | +$36.9K |
|
|
AAT
2104
American Assets Trust
AAT
$1.41B
| $638K | ﹤0.01% |
29,099
+1,735
| +6% | +$38.3K |
|
2105
GeoPark
GPRK
$608M
| $636K | ﹤0.01% |
66,247
-19,730
| -23% | -$175K |
|
|
FLNA
2106
Filana Therapeutics
FLNA
$45.7M
| $636K | ﹤0.01% |
31,327
+1,456
| +5% | +$33.5K |
|
2107
Wolverine World Wide
WWW
$1.63B
| $632K | ﹤0.01% |
56,307
+2,907
| +5% | +$26.9K |
|
2108
Forrester Research
FORR
$224M
| $631K | ﹤0.01% |
29,259
+6,988
| +31% | +$158K |
|
2109
B&G Foods
BGS
$299M
| $628K | ﹤0.01% |
54,862
+3,979
| +8% | +$41.7K |
|
2110
Nu Skin
NUS
$236M
| $625K | ﹤0.01% |
45,156
+6,502
| +17% | +$102K |
|
|
CLDT
2111
Chatham Lodging
CLDT
$601M
| $624K | ﹤0.01% |
61,705
+1,702
| +3% | +$17.8K |
|
|
HA
2112
DELISTED
Hawaiian Holdings, Inc.
HA
| $623K | ﹤0.01% |
46,730
+2,186
| +5% | +$30.4K |
|
|
HAPN
2113
Happen Inc
HAPN
$2.27B
| $622K | ﹤0.01% |
70,715
+4,479
| +7% | +$37.5K |
|
2114
PetMed Express
PETS
$43.4M
| $620K | ﹤0.01% |
129,229
+42,125
| +48% | +$245K |
|
2115
Recursion Pharmaceuticals
RXRX
$1.78B
| $619K | ﹤0.01% |
62,065
+5,501
| +10% | +$61.3K |
|
|
ZUO
2116
DELISTED
Zuora, Inc.
ZUO
| $619K | ﹤0.01% |
67,806
+4,760
| +8% | +$41.5K |
|
2117
Community Trust Bancorp
CTBI
$1.44B
| $618K | ﹤0.01% |
14,484
+631
| +5% | +$25.7K |
|
2118
Standard Motor Products
SMP
$870M
| $618K | ﹤0.01% |
18,396
+634
| +4% | +$23.2K |
|
2119
CRA International
CRAI
$1.07B
| $617K | ﹤0.01% |
4,121
+282
| +7% | +$33.4K |
|
2120
Vital Farms
VITL
$498M
| $617K | ﹤0.01% |
26,510
+1,402
| +6% | +$24.5K |
|
2121
Ethan Allen Interiors
ETD
$583M
| $612K | ﹤0.01% |
17,687
+975
| +6% | +$30.5K |
|
2122
Ingles Markets
IMKTA
$1.68B
| $609K | ﹤0.01% |
7,933
+912
| +13% | +$72.9K |
|
|
PGRE
2123
DELISTED
Paramount Group
PGRE
| $608K | ﹤0.01% |
129,471
+6,583
| +5% | +$31K |
|
|
RDFN
2124
DELISTED
Redfin
RDFN
| $608K | ﹤0.01% |
91,426
+1,088
| +1% | +$8.27K |
|
2125
Embecta
EMBC
$290M
| $606K | ﹤0.01% |
45,634
-107,604
| -70% | -$1.67M |
|
Similar funds
T. Rowe Price Associates's Q1 2024 Portfolio in Review
As of Q1 2024, T. Rowe Price Associates held 3,021 positions worth $816B, up 9.6% from $744B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
T. Rowe Price Associates's Q1 2024 filing shows 108 new, 1,941 increased, 738 reduced and 64 closed positions. Its largest new stake was GE Vernova: 2,687,194 shares worth $367M. The largest sale was NVIDIA, an estimated $2.59B.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q1 2024 buy was GE Vernova: 2,687,194 shares worth $367M.
- T. Rowe Price Associates added most to Fortinet in Q1 2024, an estimated $2.03B increase.
- T. Rowe Price Associates's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $2.59B.
- T. Rowe Price Associates fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $621M.
- T. Rowe Price Associates's ten largest holdings make up 32% of its $816B portfolio in Q1 2024.
- T. Rowe Price Associates opened 108 new positions and closed 64 in Q1 2024.
- T. Rowe Price Associates's portfolio value rose 9.6% quarter-over-quarter to $816B.
Based on T. Rowe Price Associates's 13F filing for Q1 2024, filed 15 May 2024.